Current Vaccines News and Events | Page 2

Current Vaccines News and Events, Vaccines News Articles.
Sort By: Most Relevant | Most Viewed
Page 2 of 25 | 1000 Results
Set clear rules for vaccinating health care workers against SARS-CoV-2
Provincial and territorial governments should set clear rules for vaccinating health care workers against SARS-CoV-2, the virus that causes COVID-19, in public and private settings, and should not leave this task to employers, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/content/cmaj/early/2021/01/19/cmaj.202755.full.pdf. (2021-01-19)

New method to assist fast-tracking of vaccines for pre-clinical tests
A new method to synthesize vaccines safely and quickly should see much faster pre-clinical testing to pursue strategies to combat novel pathogens, something the COVID pandemic has shown is necessary. (2021-01-18)

NIH officials highlight COVID-19 vaccine facts, unknowns for healthcare providers
Healthcare providers must be able to explain the latest data supporting the safety and efficacy of vaccines for coronavirus disease 2019 (COVID-19) so they can strongly encourage vaccination when appropriate while acknowledging that uncertainty and unknowns remain. This message comes from a new commentary co-authored by Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and other leading NIAID scientists in the journal Annals of Internal Medicine. (2021-01-18)

UW researchers develop tool to equitably distribute limited vaccines
Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person's age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs. (2021-01-15)

Physical virology shows the dynamics of virus reproduction
The reproductive cycle of viruses requires self-assembly, maturation of virus particles and, after infection, the release of genetic material into a host cell. New physics-based technologies allow scientists to study the dynamics of this cycle and may eventually lead to new treatments. (2021-01-14)

Model analyzes how viruses escape the immune system
MIT researchers have devised a way to computationally model viral escape, using models that were originally developed to model language. The model can predict which sections of viral surface proteins, including those of influenza, HIV, and SARS-CoV-2, are more likely to mutate in a way that allows the virus to evade the human immune system. It can also identify sections that are less likely to mutate, making them good targets for new vaccines. (2021-01-14)

COVID-19: Science scepticism may be reinforced by UK rush to approve vaccines
Former director of public health Professor John Ashton has said that scientific scepticism may be reinforced by the UK's rush to approve COVID vaccines for public use and the apparent political desire to be the first out of the blocks in contrast to our European neighbours. (2021-01-14)

Study: Colleges can prevent 96% of COVID-19 infections with common measures
The combined effectiveness of three COVID-prevention strategies on college campuses--mask-wearing, social distancing, and routine testing--are as effective in preventing coronavirus infections as the Pfizer and Moderna vaccines approved by US FDA, according to a new study from Case Western Reserve University. (2021-01-13)

Depression and stress could dampen efficacy of COVID-19 vaccines
Health behaviors and emotional stressors can alter the body's ability to develop an immune response to vaccines, including--potentially--the new COVID-19 vaccines. Simple interventions, including exercising and getting a good night's sleep in the 24 hours before vaccination, may maximize the vaccine's initial effectiveness. (2021-01-13)

How will SARS-CoV-2 severity change in the next decade?
What will the SARS-CoV-2 outbreak look like ten years from now as it passes from pandemic to endemic, maintained at a constant baseline level in populations without being fueled by outside infections? (2021-01-12)

Higher vaccine rates associated with indicative language by provider, more efficient
New research from Boston Medical Center finds that using clear, unambiguous language when recommending HPV vaccination both increases vaccine acceptance and increases conversation efficiency while preserving patient satisfaction. (2021-01-12)

Scientists reach new milestone in vaccine development for leishmaniasis
Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines. (2021-01-11)

Breakthrough on diarrhea virus opens up for new vaccines
Researchers at Umeå University in Sweden have for the first time at the atomic level succeeded in mapping what a virus looks like that causes diarrhea and annually kills about 50,000 children in the world. The discovery may in the long run provide the opportunity for completely new types of treatments for other viral diseases such as COVID-19. (2021-01-11)

Turbo boosters for the immune system
Immunologist Prof. Dr. Olaf Groß of the Medical Center - University of Freiburg receives a Proof of Concept Grant from the European Research Council (ERC) for his project IMMUNOSTIM. (2021-01-11)

Single-dose COVID-19 vaccine triggers antibody response in mice
Across the world, health care workers and high-risk groups are beginning to receive COVID-19 vaccines, offering hope for a return to normalcy amidst the pandemic. However, the vaccines authorized for emergency use in the U.S. require two doses to be effective, which can create problems with logistics and compliance. Now, researchers reporting in ACS Central Science have developed a nanoparticle vaccine that elicits a virus-neutralizing antibody response in mice after only a single dose. (2021-01-08)

Nanoparticle vaccine for COVID-19
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature. (2021-01-08)

Experts tap into behavioral research to promote COVID-19 vaccination in the US
Behavioral science and marketing researchers are laying out a range of strategies to help convince people to get vaccinated. (2021-01-07)

Cutting COVID-19 infectious period could prevent millions of cases
A new computational analysis suggests that a vaccine or medication that could shorten the infectious period of COVID-19 may potentially prevent millions of cases and save billions of dollars. The study was led by Bruce Lee along with colleagues in the Public Health Informatics, Computational, and Operations Research (PHICOR) team headquartered at the CUNY Graduate School of Public Health and Health Policy and the Lundquist Research Institute at Harbor-UCLA Medical Center, and publishes in the open-access journal PLOS Computational Biology. (2021-01-07)

Treating an autoimmune disease in mice with an mRNA vaccine
Christina Krienke and colleagues have designed an mRNA vaccine that delayed the onset of and reduced the severity of multiple sclerosis-like disease in mice. (2021-01-07)

New defense against dengue and emerging mosquito-borne viruses
New treatments to cut the global death rate from dengue, Zika and West Nile viruses could result from research led by The University of Queensland. Associate Professor Daniel Watterson from UQ's School of Chemistry and Molecular Biosciences said the team identified an antibody that improved survival rates in laboratory trials and reduced the presence of virus in the blood. (2021-01-07)

Study: Black Americans, women, conservatives more hesitant to trust COVID-19 vaccine
A survey of approximately 5,000 Americans suggests that 31.1 percent of the US public does not intend to get the COVID-19 vaccine once it becomes available to them - and the likelihood of vaccine refusal is highest among Black Americans, women and conservatives. (2021-01-06)

UCI study first to link disparities and 'pharmacy deserts' in California
In the United States, Black, Latino and low-income communities have historically lacked nearby access to pharmacy services. To provide the first record of these 'pharmacy deserts' in Los Angeles County, a University of California, Irvine study identified communities where the nearest pharmacy was at least one mile away. (2021-01-06)

Vaccine myths on social media can be effectively reduced with credible fact checking
Researchers found that fact-check tags located immediately below or near a social media post can generate more positive attitudes toward vaccines than misinformation alone, and perceived source expertise makes a difference. (2021-01-06)

Allergists offer reassurance regarding potential allergic reactions to COVID-19 vaccines
Reports of possible allergic reactions to COVID-19 vaccines have raised public concern; however, allergists note that allergic reactions to vaccines are rare, and COVID-19 vaccine allergic reactions will have a similarly low rate of occurrence. Individuals with a history of anaphylaxis to an injectable drug or vaccine containing polyethylene glycol or polysorbate should speak with an allergist before getting vaccinated, but patients with severe allergies to foods, oral drugs, latex or venom can safely receive the COVID-19 vaccines. (2020-12-31)

Global disparities in vaccination persist and leave many children at risk
Even before the COVID-19 pandemic, tens of millions of children worldwide were not receiving basic doses of vaccines. New research finds there continue to be significant disparities in childhood vaccination, and poorer children from under-represented and minority groups in most countries are more likely to be less fully vaccinated with all the recommended immunizations. A special supplement to the American Journal of Preventive Medicine looks at the barriers and challenges that limit or prevent access to vaccines in vulnerable children. (2020-12-22)

COVID immunity lasts up to 8 months, new data reveals
Australian researchers have revealed -- for the first time -- that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months. The research is the strongest evidence for the likelihood that vaccines against the virus, SARS-CoV-2, will work for long periods. (2020-12-22)

ACP, Annals of Internal Medicine host virtual COVID-19 Vaccine Forum II for physicians
As COVID-19 vaccines are becoming available, physicians and other health care professionals must do the hard work of making sure sufficient numbers of people are vaccinated to end the pandemic. (2020-12-21)

Improved macaque genome enhances biomedical utility
Using advanced sequencing technology, researchers present a new, improved and far more complete reference genome for the rhesus macaque - one of the most important animal models in biomedical research. (2020-12-17)

US needs clear vaccine distribution strategy to defeat coronavirus
An opinion piece published today online calls for a national vaccine strategy now that COVID-19 vaccines are available. The author writes that a lack of clarity on a distribution plan sets unrealistic expectations among the public and could undermine public trust. But even with a clearly defined strategy in place, vaccinating hundreds of millions of Americans will not be easy. (2020-12-17)

Two thirds of people with lupus would take COVID-19 vaccine, shows LRA survey
Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance (LRA). (2020-12-16)

Neutralizing antibodies protect against severe COVID-19
Scientists at the Ragon Institute of MGH, MIT and Harvard, publishing in the journal Cell, show that the potency of neutralizing antibodies which developed in COVID-19 patients was significantly reduced in those with severe or fatal disease compared to patients with milder infections. (2020-12-16)

An atlas of S. pneumoniae and host gene expression during colonization and disease
The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread to the bloodstream and cause organ damage. To understand how this pathogen adapts to different locations in the body, and also how the host responds to the microbe, researchers have measured bacterial and host gene expression at five different sites in a mouse model -- the nasopharynx, lungs, blood, heart and kidneys -- using three genetically different strains of S. pneumoniae. (2020-12-16)

Drug may boost vaccine responses in older adults
A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows. (2020-12-15)

RNA basic building block produced biocatalytically for the first time
Researchers from TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of nucleic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics. (2020-12-15)

Much of the world may not have access to a COVID-19 vaccine until 2022
Nearly a quarter of the world's population may not have access to a COVID-19 vaccine until at least 2022, warns a study published by The BMJ today. (2020-12-15)

How can we make sure people get the second COVID-19 vaccine dose?
The availability of COVID-19 will not necessarily result in people getting fully vaccinated, because the first vaccines to reach public use require two doses for full protection - and research has shown that many people never follow up on multi-dose vaccines or other multi-step preventive health practices. A researcher who has studied this effect comments on what it might take to solve the ''second dose problem.'' (2020-12-14)

One-step method to generate mice for vaccine research
To develop vaccines, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors. These mice, however, often take several years to develop, requiring a complicated process of genetic modification and careful breeding. A Ragon Institute group has developed a one-step method, which uses CRISPR/Cas9 technology, to produce mice with genetically engineered human B cell receptors in just a few weeks. (2020-12-14)

Behavioral strategies to promote a national COVID-19 vaccine program
National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at 'warp speed' will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated. (2020-12-14)

Vaccines must prevent infection, disease progression and transmission - in every country - to truly bring COVID-19 under control
An editorial co-authored by a member of the UK's influential SAGE committee that advises the UK Government on COVID-19, and published in Anaesthesia (a journal of the Association of Anaesthetists) says that in order for the global COVID-19 vaccination program to be successful, the available vaccines must be able to do all three of: prevent infection becoming established in an individual, prevent disease progression and prevent onward transmission. (2020-12-14)

A protein has been identified as a potential therapeutic target for leishmaniasis vaccines
According to the World Health Organisation (WHO), leishmaniasis causes between 20,000 and 30,000 deaths a year, and there is currently no vaccine for humans. A research team led by the Complutense University of Madrid has described the mechanism by which the Leishmania parasite avoids detection: through the SHP-1 protein, which is responsible for basic cellular functions. The finding positions this protein as a potential therapeutic target for the development of vaccines against the disease. (2020-12-11)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.